WINDTREE THERAPEUTICS INC /DE/ Retained Earnings
WINDTREE THERAPEUTICS INC /DE/ (WINT) had Retained Earnings of -$889.37 million as of 2025-09-30, per its 10-Q filed 2025-11-19.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2025-11-19
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$889.37M.
- 2025-06-30: Retained Earnings (Accumulated Deficit) -$861.29M.
- 2025-03-31: Retained Earnings (Accumulated Deficit) -$850.65M.
- 2024-12-31: Retained Earnings (Accumulated Deficit) -$846.61M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2025-09-30 | -$889.37M 10-Q · filed 2025-11-19 |
| 2025-06-30 | -$861.29M 10-Q · filed 2025-08-19 |
| 2025-03-31 | -$850.65M 10-Q · filed 2025-05-15 |
| 2024-12-31 | -$846.61M 10-Q · filed 2025-11-19 |
| 2024-09-30 | -$848.81M 10-Q · filed 2024-11-26 |
| 2024-06-30 | -$846.63M 10-Q · filed 2024-08-19 |
| 2024-03-31 | -$834.60M 10-Q · filed 2024-05-15 |
| 2023-12-31 | -$844.82M 10-K · filed 2025-04-15 |
| 2023-09-30 | -$839.67M 10-Q · filed 2023-11-09 |
| 2023-06-30 | -$835.24M 10-Q · filed 2023-08-07 |
| 2023-03-31 | -$828.64M 10-Q · filed 2023-05-15 |
| 2022-12-31 | -$824.53M 10-K · filed 2024-04-16 |
| 2022-09-30 | -$814.84M 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$810.78M 10-Q · filed 2022-08-11 |
| 2022-03-31 | -$793.45M 10-Q · filed 2022-05-05 |
| 2021-12-31 | -$785.32M 10-K · filed 2023-03-31 |
| 2021-09-30 | -$772.25M 10-Q · filed 2021-11-10 |
| 2021-06-30 | -$764.04M 10-Q · filed 2021-08-05 |
| 2021-03-31 | -$726.65M 10-Q · filed 2021-05-13 |
| 2020-12-31 | -$717.69M 10-K · filed 2022-03-31 |
| 2020-09-30 | -$710.23M 10-Q · filed 2020-11-16 |
| 2020-06-30 | -$701.21M 10-Q · filed 2020-08-14 |
| 2020-03-31 | -$691.66M 10-Q · filed 2020-05-13 |
| 2019-12-31 | -$685.12M 10-K · filed 2021-03-29 |
| 2019-09-30 | -$677.75M 10-Q · filed 2019-11-14 |
| 2019-06-30 | -$670.62M 10-Q · filed 2019-08-14 |
| 2019-03-31 | -$664.18M 10-Q · filed 2019-05-20 |
| 2018-12-31 | -$657.65M 10-K · filed 2020-04-03 |
| 2018-09-30 | -$648.61M 10-Q · filed 2018-11-14 |
| 2018-06-30 | -$644.68M 10-Q · filed 2018-08-14 |
| 2018-03-31 | -$641.63M 10-Q · filed 2018-05-21 |
| 2017-12-31 | -$637.11M 10-K/A · filed 2019-04-23 |
| 2017-09-30 | -$639.59M 10-Q · filed 2017-11-14 |
| 2017-06-30 | -$634.14M 10-Q · filed 2017-08-21 |
| 2017-03-31 | -$627.39M 10-Q · filed 2017-05-15 |
| 2016-12-31 | -$618.67M 10-K · filed 2018-04-17 |
| 2016-09-30 | -$612.07M 10-Q · filed 2016-11-14 |
| 2016-06-30 | -$603.70M 10-Q · filed 2016-08-10 |
| 2016-03-31 | -$593.08M 10-Q · filed 2016-05-12 |
| 2015-12-31 | -$579.18M 10-K · filed 2017-03-31 |
| 2015-09-30 | -$569.07M 10-Q · filed 2015-11-05 |
| 2015-06-30 | -$547.51M 10-Q · filed 2015-08-10 |
| 2015-03-31 | -$536.19M 10-Q · filed 2015-05-11 |
| 2014-12-31 | -$524.01M 10-K · filed 2016-03-29 |
| 2014-09-30 | -$513.37M 10-Q · filed 2014-11-07 |
| 2014-06-30 | -$502.05M 10-Q · filed 2014-08-07 |
| 2014-03-31 | -$491.43M 10-Q · filed 2014-05-12 |
| 2013-12-31 | -$479.95M 10-K · filed 2015-03-16 |
| 2013-09-30 | -$468.22M 10-Q · filed 2013-11-12 |
| 2013-06-30 | -$456.00M 10-Q · filed 2013-08-08 |
| 2013-03-31 | -$447.37M 10-Q · filed 2013-05-07 |
| 2012-12-31 | -$434.74M 10-K · filed 2014-03-17 |
| 2012-09-30 | -$427.92M 10-Q · filed 2012-11-14 |
| 2012-06-30 | -$414.57M 10-Q · filed 2012-08-14 |
| 2012-03-31 | -$407.44M 10-Q · filed 2012-05-15 |
| 2011-12-31 | -$397.42M 10-K · filed 2013-03-15 |
| 2011-09-30 | -$393.12M 10-Q · filed 2011-11-14 |
| 2011-06-30 | -$388.37M 10-Q · filed 2011-08-15 |
| 2010-12-31 | -$376.45M 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |